Two Positive Studies of Genentech's Atezolizumab in Specific Type of Lung Cancer Presented at 2015 ECC
September 27, 2015 at 06:44 AM EDT
Genentech, a member of the Roche Group (OTC: RHHBY), today announced positive results from two Phase II studies that ...